Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Grant supports development of Resmycin

Nov. 13, 2003

Plexxikon supplies novel kinase inhibitor to Genentech

Nov. 13, 2003

Treatment under way in ML's phase II prostate cancer study

Nov. 13, 2003

Six-month Eligard product completes phase III trial

Nov. 13, 2003

Lilly scientists discover new ERbeta agonists for use in prostate cancer

Nov. 13, 2003

Phase II dose-to-rash study of Tarceva

Nov. 12, 2003

Eligard products receive Canadian approval

Nov. 12, 2003

Hybrigenics and Servier sign new drug discovery agreements

Nov. 11, 2003

New ErbB kinase inhibitors, their preparation and use revealed in AstraZeneca patent

Nov. 11, 2003

BMS researchers present new protein kinase inhibitors for proliferative and inflammatory disorders

Nov. 11, 2003

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...